InvestorsHub Logo
Followers 7
Posts 410
Boards Moderated 0
Alias Born 06/04/2014

Re: XenaLives post# 4406

Sunday, 04/30/2017 1:37:17 PM

Sunday, April 30, 2017 1:37:17 PM

Post# of 21531
Your safety concerns are not relevant.

As you well know there was a safety module in the Ph2b study.

The Data Monitoring Committee, (DMC) an FDA mandated component of the Neurotrope study, would have picked up on any drug safety concerns with the AD patients.

If there were serious concerns they would have intervened and changed the study protocol or halted the study.

The DMC did not do that in NTRP’s Ph2b study.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News